Individualized curative treatment for malignant diseases through liver transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
https://link.springer.com/content/pdf/10.1007/s00104-023-01973-z.pdf
Reference41 articles.
1. Bhatti ABH, Naqvi W, Khan NY et al (2022) Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion. J Cancer Res Clin Oncol 148:245–253
2. Bundesärztekammer (2023) Richtlinie gem. § 16 Abs. 1 S. 1 Nrn. 2 und 5 TPG für die Wartelistenführung und Organvermittlung zur Lebertransplantation
3. Cambridge WA, Fairfield C, Powell JJ et al (2021) Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma. Ann Surg 273:240–250
4. Chan KM, Tsai CY, Yeh CN et al (2018) Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterol 18:180
5. Doussot A, Gonen M, Wiggers JK et al (2016) Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models. J Am Coll Surg 223:493–505.e2
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3